FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: antibiotic

Sort
E.g., 2013-06-18
E.g., 2013-06-18
Enter a comma separated list of user names.

OPTR, ESLR, PWRM, EXAS, EGI - Stock Report, News, and Must Watch Video!! From PennyOmega.com
Posted by pennylynnomega on April 3rd, 2011

Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced the presentation of information from insurance claims and survey databases highlighting the unmet need for targeted therapies to treat subpopulations at high risk of recurrence of Clostridium difficile infection (CDI). The research also presented the substantial mortality and frequent complications associated with CDI.

Read More
comment 0
Share
Tags:
gold, ESLR, Evergreen Solar, copper, cancer, stem cell, Alzheimer's, pwrm.ob, breast cancer, nuropro, Power 3 Medical, neurodegenerative disease, diagnostic tests, protein biomarkers, exact sciences, nasdaq:exas, ALS, patents, Rozetta-Cell, Entree Gold, Nasdaq:ESLR, bc serapro, Parkinsons, solar power products, OPTR, Optimer Pharmaceuticals, CDI, colorectal cancer, EXAS, EGI, mineral exploration company, Parkinsons disease, Lou Gehrigs Disease, otcbb:pwrm, Ivanhoe Mines, NASDAQ:OPTR, Helen Parks, Clostridium difficile infection, mortality rate, complications, Society for Healthcare Epidemiology of America, Fidaxomicin, antibiotic, colon inflammation, diarrhea, COBK, String Ribbon solar panels, molecular diagnostics company, NYSE:EGI

OPTR, PWRM, SANW, SONE, SB - Companies Helping With Diseases, Plus Must Watch Video From DrStockPick.com!!
Posted by drstockpick on April 3rd, 2011

Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced the presentation of information from insurance claims and survey databases highlighting the unmet need for targeted therapies to treat subpopulations at high risk of recurrence of Clostridium difficile infection (CDI). The research also presented the substantial mortality and frequent complications associated with CDI.

Read More
comment 0
Share
Tags:
banks, retailers, SONE, cancer, Alzheimer's, stem cells, credit unions, pwrm.ob, breast cancer, nuropro, Power 3 Medical, neurodegenerative disease, diagnostic tests, protein biomarkers, ALS, patents, S&W Seed Company, NASDAQ:SANW, SANW, NASDAQ:SONE, NYSE:SB, Safe Bulkers, SB, Rozetta-Cell, marine drybulk transportation, bc serapro, Parkinsons, Optimer Pharmaceuticals, CDI, S1, Parkinsons disease, Lou Gehrigs Disease, software products, otcbb:pwrm, NASDAQ:OPTR, Helen Parks, Clostridium difficile infection, mortality rate, complications, Society for Healthcare Epidemiology of America, Fidaxomicin, antibiotic, colon inflammation, diarrhea, alfalfa seed varieties

OPTR, PWRM, TQNT, COBK, ULU - Optimer Pharmaceuticals Helps Patients With CDI, Plus Stock News From DoubleInStocks.com!!
Posted by doubleinstocks1 on April 3rd, 2011

Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced the presentation of information from insurance claims and survey databases highlighting the unmet need for targeted therapies to treat subpopulations at high risk of recurrence of Clostridium difficile infection (CDI). The research also presented the substantial mortality and frequent complications associated with CDI. Investigator Erik R.

Read More
comment 0
Share
Tags:
cancer, stem cell, pwrm, pwrm.ob, Helen Park, breast cancer, Power3 Medical Products, nuropro, Alzheimers, neurodegenerative disease, diagnostic tests, protein biomarkers, Rozetta Cell, ALS, patents, power3, ULU, AMEX:ULU, Uluru, bc serapro, ira goldknopf, Parkinsons, Optimer Pharmaceuticals, CDI, Nasdaq:TQNT, Lou Gehrigs Disease, otcbb:pwrm, NASDAQ:OPTR, TriQuint, Colonial, Clostridium difficile infection, mortality rate, complications, Society for Healthcare Epidemiology of America, Fidaxomicin, antibiotic, colon inflammation, diarrhea, Nasdaq:COBK, TQNT, COBK

ADVERTISE WITH US